AI nudges to help people get colorectal cancer screening
Part of Cancer, Digestive system clinical trials.
This study tests whether AI-powered reminders and messages can help adults aged 45–74 who show signs of colorectal cancer risk actually complete a colonoscopy screening. The goal is to see if a smarter nudge system increases the number of people who follow through with this important test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 74 years old
- You tested positive on a colorectal cancer risk assessment and a stool blood test
- You are in generally good health and mentally able to consent to the study
- You have not had colorectal surgery or a colonoscopy/sigmoidoscopy in the past 5 years
- You do not have serious heart, brain, lung, or kidney disease
- You have not been diagnosed with cancer or are not currently being treated for cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI-powered program, including text messages and app support, can help people who are at higher risk for colorectal cancer schedule and complete a colonoscopy. If you are 40–64, had a positive screening test, and can use a smartphone, this trial may help you follow through with the recommended next step.
This trial tests whether using artificial intelligence during a colonoscopy helps doctors find abnormal growths (polyps) in the colon more effectively than a standard colonoscopy alone. It may help detect problems early and prevent colon cancer.
This study tests whether artificial intelligence can help doctors see polyps better during a screening colonoscopy. If you are between 45 and 74, have no bowel disease, and are having a routine screening, you may be able to join.
This study tests whether artificial intelligence (CAD) can help doctors find more polyps during screening colonoscopy, with the goal of lowering the risk of advanced adenomas (precancerous growths) over 3 years.
This trial uses artificial intelligence to better detect precancerous growths in the right side of the colon during a colonoscopy. It may help catch early warning signs that could lead to cancer.
This study tests whether a smart computer program (artificial intelligence) can help doctors find more polyps during a standard colonoscopy for colorectal cancer screening. It may improve detection of early signs of cancer.
Hear when a new Colonoscopy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.